Chronic Kidney Disease Trial, Recruiting NCT07591714 Sponsor: Pardis Specialized Wellness Institute Condition: Chronic Kidney Disease
Back to Chronic Kidney Disease

Chronic Kidney Disease Trial, Recruiting

NCT07591714
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older who regularly receive hemodialysis at a dialysis centre
  • People who are medically stable enough to do a brief, seated activity during their dialysis session
  • People who are able to understand and follow instructions for eye exercises
  • People who are able to give their informed consent to participate
  • People who can sit upright on their own during dialysis
  • People who are able to complete repeated assessments throughout the trial
  • People who can communicate if they feel discomfort or unwell during the trial
  • People who normally wear glasses or corrective lenses are permitted to wear them if needed

Who may not be able to join:

  • People with unstable heart conditions, such as unstable chest pain, a recent heart attack, poorly controlled heart rhythm problems, or heart failure that is not well managed
  • People who have an active infection or are acutely unwell at the time of the trial
  • People whose blood pressure or circulation is not stable
  • People with significant difficulties in thinking, understanding, or communicating that would prevent them from following instructions
  • People with severe vision problems that cannot be corrected, or who have an active eye disease
  • People who have recently had major eye surgery
  • People with serious muscle, bone, or nerve conditions that would prevent them from taking part or completing the assessments
  • People whose treating doctor or kidney specialist considers any exercise during dialysis to be unsafe for them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mohammad Ali Tabibi, Dr, Study Director Pardis Specialized Wellness Institute

Phone: +989132-51202

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Pardis Specialized Wellness Institute
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 September 2026

Where this trial is recruiting

Iran

Primary endpoints

Recruitment rate; Retention rate; Adherence rate; Safety and tolerability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov